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Abstract 
The immobilization of natural molecules on synthetic bone grafts stands as a strategy to 
enhance their biological interactions. During the early stages of healing, immune cells and 
osteoclasts (OC) modulate the inflammatory response and resorb the biomaterial, respectively. 
In this study, heparin, a naturally occurring molecule in the bone extracellular matrix, was 
covalently immobilized on biomimetic calcium-deficient hydroxyapatite (CDHA). The effect 
of heparin-functionalized CDHA on inflammation and osteoclastogenesis was investigated 
using primary human cells, and compared to pristine CDHA and beta-tricalcium phosphate (β-
TCP). Biomimetic substrates led to lower oxidative stresses by neutrophils and monocytes than 
sintered β-TCP, even though no further reduction was induced by the presence of heparin. In 
contrast, heparinized CDHA fostered osteoclastogenesis. Optical images of stained TRAP 
positive cells showed an earlier and higher presence of multinucleated cells, compatible with 
OC at 14 days, whilst pristine CDHA and β-TCP present OC at 21-28 days. Although no 
statistically significant differences were found in the OC activity, microscopy images 
evidenced early stages of degradation on heparinized CDHA, compatible with osteoclastic 
resorption. Overall, the results suggest that the functionalization with heparin fostered the 
formation and activity of OC, thus offering a promising strategy to integrate biomaterials in 
the bone remodeling cycle by increasing their OC-mediated resorption. 
 




This article is protected by copyright. All rights reserved. 
1. Introduction 
The success of synthetic bone grafts upon implantation is usually related to their ability to 
favorably modulate the host response. The interactions of the biomaterial with the host tissue 
mainly involve the immune and the skeletal systems in what nowadays is known as 
osteoimmunology (Franz, Rammelt, Scharnweber, & Simon, 2011). The immune system plays 
a role in the inflammatory response upon implantation, while the skeletal system will 
orchestrate the osteogenic/osteoclastogenic response of bone to interact with the biomaterial 
(Anderson, Rodriguez, & Chang, 2008). The resolution of this first inflammatory response is a 
required key-step for the consequent tissue repair and regeneration. The main actors involved 
in inflammation are the blood cells arriving to the injured site by extravasation. Neutrophils, 
monocytes and monocyte-derived cells, such as macrophages, are the first interacting cells. 
These trigger the biological cascade by releasing reactive oxygen and nitrogen species (ROS 
and RNS respectively), chemokines and cytokines (Zhang et al., 2013). Hence, the modulation 
of this early response has recently drawn the attention of the scientific community in an effort 
to enhance the tissue regeneration potential of biomaterials.  
Reducing or controlling inflammation upon implantation is a strategy that can foster the success 
of an implanted material (Loi et al., 2016). One interesting approach is the use of 
glycosaminoglycans (GAGs) as anti-inflammatory molecules. Hyaluronic acid, chondroitin 
sulphate and heparin have shown good anti-inflammatory properties by binding to chemo- and 
cytokines (Severin et al., 2012). The relevance of GAGs as inflammation mediators in vivo has 
recently been shown by their interaction with pro-inflammatory chemokines, such as 
interleukin–8 (CXCL8)/neutrophil-mediated inflammation (Gschwandtner et al., 2017). In 
addition, GAGs are part of the extracellular matrix (ECM), and they are known to interact with 
several signaling proteins involved not only in the immune system but also in the skeletal 
regulatory pathways (Capila & Linhardt, 2002). Recent studies have highlighted the affinity of 
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GAGs for osteogenic proteins such as bone morphogenetic proteins (BMPs) (Bramono et al., 
2012), thanks to the presence of heparin binding domains in BMPs. The degree of sulfonation 
of GAGs has been pointed as a key to control such interactions (Hempel et al., 2014). Human 
BMP-4 showed higher binding affinity to oversulfated GAGs compared to those lacking sulfate 
groups (Hintze et al., 2009). Whereas the osteogenic potential of GAGs, and specifically 
heparin has been reported, the effect on osteoclastogenesis has not yet been explored in 
combination with biomaterials, although studies have reported the singular effect as a 
supplement in cell culture media. Supplementation of sulfonated GAGs combined with 
collagen matrices or in cell culture media has shown to promote osteoblast (OB) activity and 
osteoclast adhesion and viability (Salbach-Hirsch, 2014; Salbach et al., 2012) but suppress OC 
activity when using OB supernatants previously in contact with GAGs. On the other hand, the 
direct supplementation of heparin in cell culture media using RAW murine cells also showed 
that osteoclast formation was promoted following dual exposure to RANKL and OPG: heparin-
bound OPG was found to increase the amount of RANKL available for OC maturation (Irie et 
al., 2007; Ling, Murali, Stein, van Wijnen, & Cool, 2010).  
Contrary to the aforementioned studies in which authors have solely investigated the effect of 
GAGs on osteogenic lineage by supplementing different GAGs to cell culture medium, in this 
study, we propose to exploit the capacity of GAGs to interact with the bone remodeling 
cascade, by combining them with a calcium phosphate substrate. Calcium phosphates (CaP) 
are ideal candidates to support bone regeneration, mainly because they possess a close 
resemblance to the mineral phase of bone, i.e. hydroxyapatite (HA). We have recently proved 
the osteoimmunomodulatory properties of heparinized CaP (Diez-Escudero et al., 2018). 
Recent studies have also shown enhanced biological interactions in the presence of heparin 
immobilized on collagen or CaPs matrices cultured with fibroblast, endothelial and 
mesenchymal stem cells (König et al., 2014; Lode et al., 2008).  
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Despite CaPs exhibit good performance as bone graft materials in vitro and in vivo, one of their 
main drawbacks is their poor resorption rate. Hence, promoting their resorption is fundamental 
for the replacement of bone grafts by new bone. Nevertheless, such a strategy would not be 
advised to patients suffering from osteoporosis due to the inherently high osteoclastic activity. 
The aim of the present study was to use heparin as a tool to tune the initial inflammatory 
response and osteoclastogenesis evoked by a CaP, which are crucial events in the early stages 
of bone remodeling. The effect of heparin functionalization on calcium deficient 
hydroxyapatite (CDHA) was analyzed using primary human cells to closely resemble the 
clinical scenario of bone grafts. A widely known synthetic bone graft, β-tricalcium phosphate 
(β-TCP) was used as a control, together with tissue culture polystyrene (TCPS).  
 
2. Materials and Methods 
2.1. Materials: characterization and functionalization 
CDHA was obtained by hydrolysis of α-tricalcium phosphate (α-TCP). α-TCP was 
produced by a solid state reaction at 1400 °C of calcium hydrogen phosphate (CaHPO4, 
Sigma-Aldrich, St. Louis, USA) and calcium carbonate (CaCO3, Sigma-Aldrich, St. Louis, 
USA) at a 2:1 molar ratio for 15 h and then quenched in air. The α-TCP was milled to a final 
median size of 5.2 µm (Espanol et al., 2009). α-TCP containing 2 wt.% of precipitated HA 
(PHA, Merck KGaA, Darmstadt, Germany) was mixed with a liquid phase consisting of 
distilled water at a liquid to powder (L/P) ratio of 0.35 mL/g, resulting in a paste that was 
transferred into PTFE moulds to fabricate discs of either 15 mm diameter x 2 mm thickness or 
5 mm diameter x 1 mm thickness. The discs were left to set at 37 °C for 10 days in water to 
allow for complete hydrolysis to CDHA. β-TCP discs were obtained by sintering the previously 
obtained CDHA discs at 1100 °C for 9 h and cooling down in air. 
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Phase identification was performed by XRD (Bruker, Cu Kα, 40 kV, 40 mA). Data were 
collected in 0.02° steps over the 2θ range of 10°-80° with a counting time of 2 s per step. The 
experimental patterns were compared to those of hydroxyapatite (JCPDS 09-0432), α-TCP 
(JCPDS 09-0348) and β-TCP (JCPDS 09-0169). Phase quantification was performed using 
EVA software (DIFFRAC.EVA software, Bruker) based on reference intensity ratio (RIR). 
Pore size distribution was investigated by mercury intrusion porosimetry (MIP, Autopore IV 
Micromeritics), by recording intrusion-extrusion curves from 30 to 30000 psia. The specific 
surface area (SSA) was assessed by nitrogen adsorption using the BET method (ASAP 2020, 
Micromeritics). Finally, the microstructure of the substrates was investigated by scanning 
electron microscopy (SEM, FIB Zeiss Neon40). 
Heparin immobilization was performed through an amidation reaction using a first step of 
silanization with aminopropyltrietoxysilane (APTES, Sigma-Aldrich, St. Louis, USA) 
followed by 1-(3-dimethylaminoporpyl)-3-ethylcarbodiimide (EDC, Sigma-Aldrich, St. Louis, 
USA) and N-hydrosuccinimide (NHS, Sigma-Aldrich, St. Louis, USA) adapted from literature 
(Williams, 2014) to couple heparin by its carboxyl groups. CDHA discs (2x15 mm2) were 
immersed overnight in absolute ethanol solution with 2 %v/v APTES and 3 %v/v distilled 
water under agitation at 100 rpm, in order to obtain aminated surfaces. Afterwards, the discs 
were rinsed in absolute ethanol and sonicated for 5 minutes to remove unbound heparin. 
Subsequently, heparin solutions with different concentrations (50, 100, 150, 250, 500 and 1000 
μg/mL) were prepared. Heparin was dissolved in phosphate buffered saline (PBS, Gibco) and 
activated by reducing the pH to 6.5 by the addition of hydrochloric acid (HCl, 0.1 M) for 15 
minutes in the presence of EDC/NHS. Immediately afterwards, pH was raised using sodium 
hydroxide (NaOH, 0.1 M) to 7.5, and 1 mL of activated heparin solution was poured onto the 
aminated discs and left under agitation for 2 h for coupling. Supernatants were collected and 
the concentration of heparin was determined through an indirect colorimetric method based on 
 
 
This article is protected by copyright. All rights reserved. 
toluidine blue, adapted from the literature (Ahola et al., 2001). Finally, the heparinized discs 
(CDHA-H) were rinsed in PBS and sonicated for 5 minutes in order to remove non-covalently 
attached heparin. 
2.2. Inflammatory response 
Monocytes and neutrophils were isolated in a two-step procedure from human buffy 
coats from volunteer donors at Uppsala University Hospital. Briefly, for monocyte 
isolation, 15mL of human blood diluted in PBS (1:1) was layered onto Ficoll-Paque 
Plus (GE Healthcare) and monocytes were isolated by density gradient centrifugation. 
The upper plasma layer was collected and stored at 4 °C for later use. The mononuclear 
ring was collected and washed 3 times with PBS. Cells were resuspended in PBS and 
counted by exclusion method using Trypan blue (1:5) in a cytometer. Neutrophils 
underwent a second separation step using 20 mL of 3% dextran in 0.9% saline solution. 
After 25 minutes, the supernatant was centrifuged and treated with 0.2% saline solution 
for 20 seconds to remove erythrocytes. The cell suspension was further centrifuged, 
resuspended in PBS, and a solution containing 6 wt.% acetic acid was used to count 
cells in a cytometer. 
Both cell types were diluted in cell culture media (4PBS/1RPMI-1640/100mM glucose) 
at a density of 1·106 cells/mL. Prior to seeding, 5x1 mm2 discs were placed in 96 white 
opaque well plates (Perkin Elmer) and sterilized with 70% ethanol for 3 hours, followed 
by thrice rinsing with PBS for 15 minutes each prior to cell seeding. 200 µL of cells 
were added to the discs, immediately followed by the addition of 100 µL of luminol 
solution (500 µM). Cells were activated with 1 µM phorbol-12-myristate-13-acetate 
(PMA, Sigma Aldrich), while cells placed onto TCPS without any PMA stimulation 
were used as a negative control. 
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Luminol-amplified chemiluminescence was used to study the inflammatory response of 
cells in contact with the discs (5x1 mm2) by monitoring the release of reactive oxygen 
species over a period of 2 hours. Luminol solution was prepared from stock solution (50 
mM of luminol in 0.2 M NaOH) mixing 1% luminol stock and 0.2% horseradish 
peroxidase (1 mg/mL). For the plasma-containing studies, 10% of human plasma was 
added to the cell medium. Luminescence was monitored at 37 °C every 2 min over 2 
hours, as previously described (Mestres et al., 2015). Triplicates for each material were 
used and the experiment was repeated twice with independent buffy coats for each cell 
type. 
2.3. Culture of osteoclast precursor (OCP) cells 
Peripheral blood mononuclear cells (PBMC), containing the precursors of human 
osteoclasts (OCP), were isolated from buffy coats of healthy voluntary blood donors to 
the National Blood Transfusion Service. Donation was anonymous, and institutional 
review board (IRB) approval was not required. Density centrifugation with Ficoll-
Histopaque gradient (Sigma–Aldrich) was used to isolate the mononuclear cells as 
earlier described (Ciapetti et al., 2017). Cells were resuspended in Dulbecco’s Modified 
Eagle’s Medium–High Glucose (DMEM, Euroclone, Milan, Italy) supplemented with 
10% fetal bovine serum (FBS, Euroclone) and 1% Penicillin/Streptomycin, to provide 
the complete DMEM. CDHA, CDHA-H, β-TCP and TCPS were sterilized using 70% 
ethanol for 3h, followed by three rinses with PBS for 15 min each. Complete medium 
was added after the sterilization and kept overnight prior to cell seeding, as 
preconditioning treatment to minimize ionic exchange.  
Mononuclear cells were resuspended in complete DMEM and seeded on discs and TCPS 
at a density of 6·106 cells/cm2 and 3·106 cells/cm2, respectively. After 2 h of incubation, 
non-adherent cells were gently removed and complete DMEM supplemented with 25% 
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osteoblast supernatant (differentiation medium). As previously reported (Avnet et al. 
2011), osteoblast supernatant contains RANKL, and has been proven as differentiation 
medium yielding similar results as those with supplementation of recombinant RANKL 
and M-CSF (Granchi et al. 2004). Cell cultures were performed up to 28 days and 
differentiation medium was refreshed every 3 days.  
2.3.1. OCP morphology 
Osteoclast morphology at 14, 21 and 28 days of culture was investigated by SEM (FIB 
Zeiss Neon40). At each time point, cells were rinsed with PBS and fixed using 2% 
paraformaldehyde/2% glutaraldehyde in 0.1 M cacodylate buffer overnight at 4 °C. 
Afterwards, samples were dehydrated in ethanol and dried. A thin carbon layer was 
sputtered prior to imaging to impart conductivity to samples. 
Tartrate-resistant acid phosphatase and Hoechst 33258 staining (TRAP-Hoechst, Sigma 
Aldrich) at 14, 21 and 28 days was used to study OC morphology and differentiation. 
At each time point, cells were fixed using 3% paraformaldehyde-2% sucrose for 30 min. 
Afterwards, the cell membrane was permeabilized with Triton 0.5% in 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) for 5 min at room temperature, 
and finally stained using naphthol AS-BI phosphoric acid and tartrate solution (Acid 
Phosphatase kit, Sigma–Aldrich) for 60 min at 37 °C for the cytoplasm and 2.25 µg/mL 
of Hoechst 33258 for 10 min in the dark for the nuclei. TRAP-Hoechst stained samples 
were analyzed by fluorescence microscopy at 360 nm excitation and 470 nm emission. 
ImageJ software was used to perform a semi-quantitative analysis of the multinucleated 
cells found by optical microscopy. Duplicates of 5x1 mm2 material discs and duplicates 
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2.3.2. OC activity 
In order to assess the OC differentiation, tartrate-resistant acid phosphatase (TRAP) 
activity was quantified both in cell lysates and culture supernatants at the end of the 
culture (28 days). Briefly, cells grown on the material substrates were rinsed in PBS and 
lysed with 0.1% Triton X-100/1 M NaCl (Sigma-Aldrich). 50 μL of the cell lysate was 
transferred to a new plate and 50 μL 4-nitrophenyl phosphate (4.61 mg/mL)/40 mM Na-
tartrate/50 mM Na-acetate (pH 4.8) were added. After 1 hour incubation at 37 °C, the 
reaction was stopped with 50 μL of sodium hydroxide (NaOH, 0.2M), and the 
absorbance was measured at 405 nm in a spectrophotometer (Infinite F200 Pro 
Microplate Reader; TECAN, Mannedorf, Switzerland). Bicinchoninic acid colorimetric 
assay (BCA, Pierce BCA Protein Assay Kit, Rockford, USA) was used to quantify the 
total protein in lysates according to the manufacturer’s instructions. Material substrates 
without cells (blank) were measured and subtracted from cell-seeded materials. TRAP 
activity was then normalized to the total protein content after blank subtraction.  
Tartrate-resistant acid phosphatase isoform 5b (TRAP5b) concentration was 
investigated after 28 days of culture. Cell supernatants were collected, centrifuged at 
400g for 5 min and assayed using the BoneTRAP® Assay kit (Pantec S.r.l., Torino, 
Italy), according to the manufacturer's instructions. The concentration of TRAP5b 
protein in the supernatants was determined by reading the absorbance at 405 nm in the 
spectrophotometer. Data are expressed as the mean concentration (units/liter) after 
subtraction of the corresponding cell-free readout. 
Calcium release and pH were monitored over cell culture time at 0, 3, 7, 14, 21 and 28 
days. At each time point, the supernatants were collected, centrifuged at 2800 rpm for 5 
minutes and kept at 4°C until measurement. Calcium release was measured using a 
colorimetric method based on ortho-cresolphthalein complexone (OCPC, Sigma-
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Aldrich) adapted from literature (Sariibrahimoglu, Leeuwenburgh, Wolke, Yubao, & 
Jansen, 2012). The absorbance was measured at 570 nm using a UV-vis 
spectrophotometer (Infinite M200 Pro Microplate Reader; TECAN, Manndorf, 
Switzerland). The pH value was measured using a pH-meter (MultiMeter MM 41).  
2.4. Statistical analyses 
 
Triplicates of 15x2 mm2 and 5x1 mm2 material discs were used for all experiments. Data 
are represented as the mean value ± standard error of the mean. Data sets for TRAP 
measurements and multinucleated cell counting were normally distributed 
(homogeneous variance, Levene> 0.05) and analyzed using one-way ANOVA, with 
post-hoc Tukey test used to assess significant differences. The data set for the number 
of nuclei was not normally distributed and non-parametric Kruskal-Wallis was used to 
assess significant differences. Values of p<0.05 were considered significant. All 
statistics were performed using IBM® SPSS® Statistics 24 software. 
 
3. Results  
3.1. Materials characterization  
Phase composition as measured by XRD (Figure 1A) showed that CDHA consisted of 
a poorly crystalline hydroxyapatite phase (JCPDS 09-0432), as indicated by the broad 
peaks. A small amount of unreacted α-TCP was detected (JCPDS 09-0348), accounting 
for 2 wt.%, as quantified by EVA Software. β-TCP samples were phase-pure and 
showed the sharp peaks typical of crystalline sintered materials (JCPDS 09-0169). 
According to MIP analysis (Figure 1B), CDHA exhibited a broad pore size distribution 
ranging from 10 to 100 nm. In contrast, β-TCP specimens presented larger pores, 
centered around 1 µm, although they also exhibited some nanoporosity. The total 
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porosity was similar for both substrates (Figure 1C), but the microstructure of the two 
ceramic substrates was clearly different. Whereas CDHA consisted of an entangled 
network of plate-like crystals, β-TCP presented a smooth polyhedral grain 
microstructure (Figure 1C, a and b), which resulted in very different values of SSA, i.e. 
24 m2/g for CDHA and 0.4 m2/g for β-TCP. Finally, the results of total heparin 
immobilization on the substrates are displayed in Figure 1D, together with an inset 
showing that the plate-like nanostructure of CDHA was preserved after heparin 
functionalization. The maximum covalent attachment yield was achieved with 
concentrations above 500 µg/mL, which allowed for the immobilization of 
approximately 200 µg of heparin on the surface of 2x15 mm2 diameter discs.  
3.2. Inflammatory response  
The release of ROS by neutrophils and monocytes activated with PMA in contact with 
the different substrates is depicted in Figure 2A and B, respectively. The inflammatory 
response of neutrophils with and without plasma is shown in Figure 2A. CDHA 
exhibited the lowest ROS release among all substrates either with or without plasma, 
followed by CDHA-H and β-TCP. All PMA-stimulated substrates showed a peak within 
the first 5 min. Plasma-containing samples showed a slight increase in ROS signal 
compared to samples with an absence of plasma. No release of ROS was observed in 
the negative control (TCPS) without PMA activation. The values of ROS release by 
monocytes was slightly higher than that of neutrophils (Figure 2B); however, ROS peaks were 
shifted to a longer time (20 min). The cells on activated TCPS (TCPS+) showed bimodal ROS 
release kinetics, with two ROS peaks at 20 and 50 min. Monocytes on biomimetic substrates 
CDHA and CDHA-H exhibited the lowest ROS signals, approximately 60% and 30%, in the 
presence and absence of plasma respectively, showing a mean peak at 20 min in all substrates 
(Figure 2B). The presence of plasma increased the release of ROS for both CDHA and CDHA-
 
 
This article is protected by copyright. All rights reserved. 
H, though it diminished after 1h to half of its value. No effect of plasma was found for β-TCP, 
which yielded approximately 70-80% of ROS regardless of the presence or lack of human 
plasma.  
3.3. OCP cells morphology  
The evolution of OCP cell morphology was qualitatively evaluated by SEM. Figure 3 
shows the cell morphology (purple color) on the different substrates at 14, 21 and 28 
days. Round cells were found on TCPS at 14 days, which became bigger and more 
spread after 21 and 28 days. At 28 days, protuberances surrounded by a flat halo were 
visible for all cells, compatible with mature OC morphology. The β-TCP substrate 
showed a high number of round cells at 14 days, which spread and showed several 
connecting filopodia at 21 and 28 days. Biomimetic substrates, CDHA and CDHA-H, 
also supported OC adhesion as shown in the images at 14 days. After 21 days, cells on 
CDHA-H appeared more elongated than on CDHA, and at 28 days the presence of cell 
clusters was observed in some regions of the samples, particularly on CDHA-H surfaces. 
Higher magnification images of the cells on CDHA-H at 28 days (Figure 3m) showed 
regions with degraded crystals (arrows) compared to the pristine plate-like 
microstructure of the material (*). This was compatible with OC resorption and was 
especially evident close to the cells (Figure 3m and n). Figure 3o shows a region totally 
covered by cells on CDHA-H. A higher magnification image (Figure 3p) displays 
degraded plate-like crystals (arrows) typical of CDHA in the zones adjacent to OC 
compared to the pristine nanostructure (*).  
The differentiation of OCP cells was monitored using TRAP-Hoechst staining at each 
time point (14, 21 and 28 days). Fewer adherent cells were observed on the biomimetic 
substrates compared to sintered β-TCP. At 14 days, multinucleated cells were evident 
only on TCPS and CDHA-H (Figure 4D and J, black arrows). This aspect was 
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maintained over 21 and 28 days for both substrates (Figure 4E and F for CDHA-H, and 
Figure 5K and L for TCPS). Only at 28 days were some multinucleated cells found on 
CDHA and β-TCP (Figure 4C and Figure 4I, respectively), even if few cell clusters were 
visible already at 14 and 21 days for CDHA (Fig. 4A and B). 
Image analyses based on the TRAP-Hoechst optical images allowed quantitative 
information to be obtained and were used to disclose the cell behavior on the different 
substrates (Figure 4M). A high number of multinucleated cells were found on TCPS at 
14 days, which increased with time (21 and 28 days). CaP substrates hosted a lower 
number of multinucleated cells compared to TCPS. For CDHA, the presence of heparin 
(CDHA-H) resulted in a higher number of multinucleated cells at all-time points, 
whereas β-TCP and pristine CDHA showed a lower number of multinucleated cells. A 
more in-depth study on the morphology of the multinucleated cells revealed different 
fusion patterns over time. Figure 4N shows the prevalent cells with different numbers 
of nuclei. The substrates hosting the highest number of multinucleated cells, i.e. CDHA-
H and TCPS, showed also a higher number of cells with 3 to 5 or 6 to 10 nuclei 
regardless of time, compatible with OC maturation. 
3.3. OC activity  
To assess the osteoclastic differentiation of OCP, TRAP activity was assessed on both 
culture supernatants and cells, the last normalized to the total protein content. Figure 5A 
shows the total protein in the cell lysates at 28 days. Heparinized CDHA-H showed the 
highest protein content, followed by CDHA and β-TCP, with TCPS scoring the lowest 
protein content. Similar levels of TRAP activity normalized to the protein content were 
observed for the OCP cells cultured on the different CaP substrates, all of them 
significantly lower than the values found for the cells cultured on TCPS (Figure. 5B). 
The presence of heparin resulted in a decrease of TRAP activity, although the difference 
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with the pristine CDHA was not statistically significant. Moreover, TRAP5b, an active 
enzyme released by differentiated OC capable of degrading bone matrix proteins was 
investigated in culture supernatants after 28 days. Analogously to what was found for 
TRAP activity, the concentration of the TRAP5b isoform released by the cells cultured 
on the CaP substrates was lower than that of the cells cultured on the control TCPS, and 
similar for all the materials (Figure 5C).  
Osteoclast activity can also be analyzed in terms of substrate degradation and the 
consequent calcium release and pH change due to the resorptive activity of OC. Figure 
6A represents the Ca2+ concentration in the cell culture medium at each time point. The 
highest Ca2+ concentration was registered when OC precursors were cultured on β-TCP. 
Both biomimetic substrates were found to subtract calcium from the medium with time, 
showing similar Ca2+ values irrespective of heparin functionalization (Figure 6B). Yet, 
in presence of cells, the concentration of Ca2+ in the culture medium increased in all 
substrates. In contrast, the cell culture medium showed a slight decrease of pH in the 
presence of cells for all substrates, which was more pronounced on the CaP substrates, 
especially at early time points (Figure 6C). The variation of pH comparing cells vs. no 
cells showed higher acidification for CDHA-H and β-TCP maintained over time (Figure 
6D). 
4. Discussion 
The initial cellular responses that follow biomaterial implantation are firstly modulated 
by the ROS release activating signal transduction pathways (Loi et al., 2016). CaP 
ceramics, such HA and β-TCP are known to evoke a consistent inflammatory cell 
response when tested as particles or following the resorption of calcium-containing 
biomaterials (Velard, Braux, Amedee, & Laquerriere, 2013). In addition, the topography 
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of CaP has also been shown to play a major role in inflammation (Mestres et al., 2015). 
Recently, some authors explored the immune response to GAGs claiming an anti-
inflammatory effect of particular GAGs, such as heparin (Ting et al., 2013; Zhou, 
Niepel, Saretia, & Groth, 2016). This was not confirmed in the present study, since, in 
fact, lower ROS levels were recorded when monocytes and neutrophils were cultured 
on pristine CDHA compared to CDHA-H. In addition, the anti-oxidant effect of human 
plasma, attributed to the scavenging role of proteins, mainly albumin, was not observed 
(Das et al., 2017). Although the neutrophil response was not particularly affected by the 
presence of plasma, monocytes presented the opposite trend, with lower percentages of 
ROS in the absence of plasma (Figure 2B). Among the different CaP substrates, 
biomimetic CDHA and CDHA-H induced the lowest ROS release under PMA 
activation, irrespective of the presence or not of heparin (Figure 2A and B), which 
confirms that no specific response was activated upon monocyte or neutrophil contact 
with heparin. Sintered β-TCP yielded the higher oxidative stress among all CaP 
substrates, in agreement with previous results (Yamada, Minamikawa, Ueno, Sakurai, 
& Ogawa, 2012). 
Three main molecules play pivotal roles in the OC maturation from OCP or 
macrophages, RANKL, OPG and M-CSF (Teitelbaum, 2000) which are secreted by 
stromal cells and osteoblasts. The balance RANKL and OPG, a decoy receptor that 
competes with RANK for RANKL, usually dictates osteoclastogenesis. Inhibition of 
osteoclastogenesis occurs when OPG binds to RANKL; on the contrary, stromal cells 
and osteoblasts can secrete higher doses of RANKL to enhance bone resorption.  
One of the limiting factors of hydroxyapatite is its poor resorbability. Hence, our 
hypothesis was that heparin functionalization could be used to enhance osteoclast 
formation and the cell-mediated resorption of apatitic substrates, by acting on the 
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RANKL/OPG balance. Previous studies have shown that direct supplementation of 
heparin in the cell culture media interfered with OPG, leaving higher amounts of 
RANKL available for OC maturation (Lamoureux, Baud’huin, Duplomb, Heymann, & 
Rédini, 2007, Irie et al., 2007). This hypothesis was tested by culturing primary human 
osteoclast precursor cells on the surface of a biomimetic CDHA covalently 
functionalized with heparin (CDHA-H), and comparing the cell response with that on 
pristine CDHA and a more resorbable CaP such as β-TCP. Covalent immobilization was 
preferred in order to discard any possible effects from heparin release during cell 
cultures. Upon grafting, sonication and three rinsing steps were performed to remove 
unbound heparin prior to cell studies. Quantification of heparin in the rinses prove that 
above 80% of the heparin remained firmly attached (data not shown). 
Although the present work has limitations regarding the full assessment of OC 
phenotype, the effect of heparin was clearly demonstrated by TRAP-Hoechst staining 
(Figure 4). Even if macrophage fusion and OC formation was lower in number on CaP 
substrates than on control TCPS, the presence of heparin (CDHA-H, Figure 4D, E, F) 
significantly increased the number of multinucleated cells compared to pristine CDHA 
or β-TCP (Figure 4A, B, C and Figure 4G, H, I, respectively). A relevant measure to 
conclude the OPG sequestering effect due to the heparin and hence confirm the pro-
osteoclastogenic effect is to investigate the possible uptake of RANKL-OPG by 
heparinized substrates at both the beginning and the end of cell studies. Another 
important aspect that has to be further investigated is whether the substrates could lead 
to the formation of foreign body giant cells (FBGC), which are related to OCs and are 
also multinucleated cells. FBGCs are usually TRAP-positive, but nevertheless they 
possess higher number of nuclei (>10) (ten Harkel et al., 2015). The formation of 
multinucleated cells with less than 10 nuclei was evident on all substrates, except for β-
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TCP at 14 days (Figure 4M). Multinucleated cells (>3 nuclei) were found on CDHA-H 
at 14 days (Figure 4D), while on the pristine substrates similar OCs were found only 
after 21 or 28 days (Figure 4B and C), and in smaller amounts. Sintered β-TCP and 
CDHA had similar number of OCs formed at 28 days (Figure 4I and C, respectively). 
Overall, the presence of heparin on CDHA-H resulted in an enhancement of 
osteoclastogenesis, similar to TCPS although the cell number was smaller, probably due 
to the CDHA roughness, which might hamper cell adhesion. Maturation of OC on HA 
substrates after 10 to 13 days has been reported, showing preferential differentiation of 
rat bone marrow cells on nanostructured alumina and HA compared to microstructured 
surfaces (Webster, 2001). Other authors have pointed to a preferential OC maturation 
on smooth surfaces, due to disruption of OC actin sealing zones on rougher surfaces 
(Costa et al., 2013). Likewise, an increase in the surface area, microporosity and 
wettability of biomaterial surface has been reported to decrease OC differentiation and 
function, compared to microsized grain topography (Costa-Rodrigues, Carmo, 
Perpétuo, Monteiro, & Fernandes, 2016). 
Recently, in a previous work, we demonstrated that rough surfaces, such as biomimetic 
CDHA with different nanotopographies, were permissive for OC formation after 21 
days (Ciapetti et al., 2017). Even if no resorption pits were clearly evident from SEM 
analysis in similar materials, early stages of OC activity were detected using focused 
ion beam (FIB) to transversally section the cells and the underlying substrate (Diez-
Escudero et al., 2017). Likewise, in the present study, although it was difficult to identify 
resorption pits on the CaP substrates (Figure 3), after 28 days of culture, degraded 
regions were found in the vicinity of cells (Figure 3m-p), compatible with OC resorptive 
activity, as observed in previous studies (Leeuwenburgh et al., 2001; Schilling et al., 
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2004). Both authors found morphological changes in the microstructure of their 
substrates upon contact with OC.  
Besides multinuclearity, TRAP activity and TRAP5b release by OC were also 
investigated after 28 days. No conclusive information can be drawn from both analyses 
since no significant differences were found among the different CaP substrates (Figure 
5). Since cell fusion was already detected after 14 days for CDHA-H or 21 days for the 
other CaP substrates, one possible explanation could be that 28 days was too late a time 
point, with the peak of TRAP5b expression occurring earlier. Remarkable differences 
in TRAP and TRAP5b were noticed only when CaP substrates were compared to TCPS. 
These results also suggest that additional studies to conclusively support the effect of 
heparin on improved osteoclastogenesis are required, such as osteoclastic markers by 
gene expression. However, sulfated GAGs have been reported to strongly interfere in 
RNA to DNA preparations (Salbach et al., 2012), and alternative methods might be 
required. 
Indirect information on OC activity can be inferred from the extracellular calcium and 
pH measurements, both being parameters indicative of OC activity (Schilling et al., 
2004). Osteoclastic resorption of the substrate should lead to an increase in Ca2+ 
concentration in the culture medium. However, this can be masked by the variations in 
calcium merely caused by the interaction of the culture medium with the CaP substrates, 
even with the absence of cells. The CaPs analyzed in this study are prone to uptake of 
calcium from cell culture medium, especially CDHA (Sadowska, Guillem-Marti, 
Montufar, Espanol, & Ginebra, 2017). Due to this inherent uptake, the evaluation of OC 
activity on such substrates can be tricky. Nevertheless, CDHA and CDHA-H in the 
presence of cells showed a reduction in the calcium uptake, compatible with the 
resorption activity of OC. The increase in Ca2+ concentration was more marked for β-
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TCP (Figure 6A, B), which could be related to its higher solubility compared to CDHA. 
Additionally, an acidification of the cell culture medium, which is related to OC activity 
(Kato & Morita, 2013), was found for all CaP substrates in the presence of cells, 
compared to TCPS (Figure 6D). β-TCP showed the highest pH variations, followed by 
CDHA-H, which were maintained over the time points of the experiment. 
Overall, the presence of a high number of multinucleated cells on CDHA-H indicates 
that heparin plays an important role as an osteoclastogenesis modulator in primary 
human cells. Additionally, SEM images supported the OC activity as evidenced by the 
degraded microstructures adjacent to the cells. In agreement with literature (Lamoureux 
et al., 2007), we hypothesize that the effect of heparin on OC maturation could be due 
to changes the OPG/RANKL balance. 
These findings, coupled with the recently reported osteoimmunomodulatory effect of 
heparinized surfaces on MSC differentiation (Diez-Escudero et al., 2018), support the 
development of heparin-mimicking materials as a tool to promote the integration of 
regenerative bone graft materials in the bone remodeling process, with minimal 
inflammatory responses and enhanced cellular signaling. 
 
5. Conclusions 
Despite the fact that heparin functionalization of biomimetic CDHA could not 
downregulate ROS release, which was already low on nanostructured CDHA compared 
to sintered microstructured β-TCP, heparin was shown to selectively stimulate human 
OCP cells fusion and maturation. Early OC maturation was demonstrated on 
heparinized substrates at 14 days, which was believed to be the reason for the low 
activity registered for TRAP and TRAP5b at 28 days. SEM analyses further confirmed 
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the presence of degraded regions on heparinized CDHA as a result of OC activity. 
Overall, this study demonstrates the enhancement of osteoclastogenesis due to the 
presence of heparin on biomimetic CDHA. This strategy represents a promising tool to 
help integrate biomaterials in the bone remodeling cycle. Nevertheless, the overall effect 
of heparin on osteoclastogenesis should be further tested by analyzing the OC 
phenotype, and consequently followed by in vivo studies.  
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Figure 1. Physicochemical properties of CaP substrates. A: XRD patterns of CDHA and β-
TCP; B: pore entrance size distribution; C: Specific surface area (SSA) and porosity values 
with representative SEM microstructures for CDHA and β-TCP (a and b, respectively, scale 
bar: 2 µm); D: maximum heparin immobilized on substrate surface (inset: microstructure of 
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Figure 2. ROS release kinetics of neutrophils (A) and monocytes (B) in contact with 
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Figure 3. SEM images of osteoclast precursor cells cultured on the substrates at different 
time points (14 days, first column; 21 days, second column, and 28 days, third column); A, B, 
C: CDHA; D, E, F: CDHA-H; G, H, I: β-TCP, and J, K, L: TCPS.  Scale bar: 20 µm. m-p: 
Detail of OCP cells on CDHA-H after 28 days of culture, showing Howship lacunae and 
degraded crystals consistent with OC resorptive activity. m: low magnification image 
showing a resorption pit (white arrows) with degraded crystals compared to pristine 
microstructure (*); n: high magnification image showing the resorption area; o: region totally 
covered by cells; and p: higher magnification image showing degraded crystals (white 
arrows) compared to the pristine plate-like crystal morphology (*) at the zone adjacent to 
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Figure 4. TRAP-Hoechst staining showing OCP differentiation over time on CDHA (A, B 
and C), CDHA-H (D, E and F), β-TCP (G, H and I) and TCPS (I, K and L).). Scale bar: 25 
µm. Black arrows indicate multinucleated cells. M: Number of multinucleated cells on the 
different substrates at each time point analyzed by ImageJ. Groups identified by the same 
superscripts are not statistically different (p>0.05). Numbers indicate differences between 
time points for each substrates, and letters indicate differences between substrates at each 
time point. N: Distribution of multinucleated cells according to the number of nuclei at 
different time points of culture. Letters indicated differences in substrates for each type of 
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Figure 5. OC TRAP activity (A and B), and TRAP5b release (C). A: Total protein in the 
OCP cells cultured for 28 days, determined in the cell lysates by BCA (# indicates differences 
compared to CDHA-H); B: TRAP activity normalized to total protein in the cell lysates (* 
indicates differences compared to TCPS); C: TRAP5b isoform enzyme released in the 
supernatants, measured by ELISA (* indicates differences compared to TCPS). Statistical 
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Figure 6. Evolution of the extracellular calcium concentration (A) and pH values (C) in the 
cell culture medium in presence (full symbols) and absence (hollow symbols) of OCP cells 
from 0 days (after preconditioning) to 28 days. Each time point represents the average of 
triplicates, with the corresponding standard deviation. The relative variation of calcium and 
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